Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said: “We’re deeply disappointed that the government’...

22 February 2022

Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “Every year 55,000 UK women and 370 men are diagnosed with...

22 February 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s utterly devastating that an estimated up to 680 additional women could...

15 February 2022

Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said: “That half of women in England with potential...

10 February 2022

New research findings published in the New England Journal of Medicine, that found that pembrolizumab, if given in combination with chemotherapy...

10 February 2022

Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s highly alarming that increasing numbers of women with potential breast...

7 February 2022

Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, who hosted the UK Interdisciplinary Breast Cancer Symposium...

31 January 2022

Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “Every year 55,000 UK women and 370 men are diagnosed with...

19 January 2022

The Scottish Medicines Consortium (SMC) has today announced its decision to recommend two new treatments – trastuzumab deruxtecan (Enhertu) and...

17 January 2022